An article published Online First in The Lancet Oncology reports that adding cetuximab to neoadjuvant chemotherapy can shrink tumours and lead to increased potentially curative surgery in patients who have colorectal cancer with inoperable metastatic liver lesions.
Link:http://www.medicalnewstoday.com/articles/172205.php
Source:Medical News Today